An update on the pharmacological management of acute respiratory distress syndrome

医学 急性呼吸窘迫 重症监护医学 内科学 肺
作者
Denise Battaglini,Ida Giorgia Iavarone,Patrícia R. M. Rocco
出处
期刊:Expert Opinion on Pharmacotherapy [Taylor & Francis]
卷期号:25 (9): 1229-1247 被引量:11
标识
DOI:10.1080/14656566.2024.2374461
摘要

INTRODUCTION: Acute respiratory distress syndrome (ARDS) is characterized by acute inflammatory injury to the lungs, alterations in vascular permeability, loss of aerated tissue, bilateral infiltrates, and refractory hypoxemia. ARDS is considered a heterogeneous syndrome, which complicates the search for effective therapies. The goal of this review is to provide an update on the pharmacological management of ARDS. AREAS COVERED: The difficulties in finding effective pharmacological therapies are mainly due to the challenges in designing clinical trials for this unique, varied population of critically ill patients. Recently, some trials have been retrospectively analyzed by dividing patients into hyper-inflammatory and hypo-inflammatory sub-phenotypes. This approach has led to significant outcome improvements with some pharmacological treatments that previously failed to demonstrate efficacy, which suggests that a more precise selection of ARDS patients for clinical trials could be the key to identifying effective pharmacotherapies. This review is provided after searching the main studies on this topics on the PubMed and clinicaltrials.gov databases. EXPERT OPINION: The future of ARDS therapy lies in precision medicine, innovative approaches to drug delivery, immunomodulation, cell-based therapies, and robust clinical trial designs. These should lead to more effective and personalized treatments for patients with ARDS.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
kevin231完成签到,获得积分10
1秒前
1秒前
Ava的应助被Lu采纳,获得10
1秒前
NexusExplorer的应助被都会有采纳,获得10
2秒前
脑洞疼的应助被lhz采纳,获得10
2秒前
CipherSage的应助被加油采纳,获得10
3秒前
华仔的应助被加油采纳,获得10
3秒前
李健的应助被奋斗的凌青采纳,获得30
3秒前
CarryLJR发布了新的文献求助30
3秒前
科目三的应助被温暖砖头采纳,获得10
4秒前
4秒前
美满怀绿发布了新的文献求助10
4秒前
CipherSage的应助被LHM采纳,获得10
4秒前
传奇3的应助被LHM采纳,获得10
4秒前
大巧若拙完成签到,获得积分10
5秒前
5秒前
Xlinging完成签到,获得积分10
5秒前
orixero的应助被拼搏的似狮采纳,获得10
6秒前
ohyeah完成签到,获得积分10
6秒前
murphy完成签到,获得积分10
6秒前
6秒前
7秒前
陈旻完成签到,获得积分10
7秒前
迨你个迨迨完成签到,获得积分10
7秒前
gem完成签到 ,获得积分10
7秒前
9秒前
9秒前
xiaomings007发布了新的文献求助10
9秒前
10秒前
传奇3的应助被XiYang采纳,获得10
10秒前
pfliu完成签到,获得积分10
10秒前
11秒前
传统的无色完成签到,获得积分10
12秒前
SAKURA的应助被绒绒采纳,获得10
12秒前
无极微光的应助被陌路采纳,获得20
12秒前
12秒前
qq完成签到,获得积分10
12秒前
芽芽发布了新的文献求助100
13秒前
13秒前
叶牧尘的应助被樱桃小丸子采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175556
求助须知:如何正确求助?哪些是违规求助? 9567240
关于积分的说明 21791502
捐赠科研通 7770174
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299